Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
Please note the ANZCTR will be unattended on Monday the 7th of October for the Labour Day public holiday.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12612000647831
Ethics application status
Approved
Date submitted
18/06/2012
Date registered
19/06/2012
Date last updated
5/04/2013
Type of registration
Prospectively registered
Titles & IDs
Public title
Impact of a probiotic supplement on post-quake psychological distress and related biomarkers
Query!
Scientific title
An investigation of the effects of a probiotic supplement on post-quake psychological distress and related biomarkers: a double-blind randomized placebo controlled trial with open label extension in people who were in Christchurch at the time of the one of the major earthquakes
Query!
Secondary ID [1]
280540
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Stress
286538
0
Query!
Depression
286539
0
Query!
Physical health
286565
0
Query!
Condition category
Condition code
Mental Health
286804
286804
0
0
Query!
Other mental health disorders
Query!
Inflammatory and Immune System
286805
286805
0
0
Query!
Other inflammatory or immune system disorders
Query!
Diet and Nutrition
286835
286835
0
0
Query!
Other diet and nutrition disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Double-blind randomized controlled trial (RCT) comparing a probiotic supplement (Probio'Stick) with a placebo followed by an open-label extension. The intervention requires the intake of a probiotic formula called Probio'Stick and containing two bacterial strains: Lactobacillus Helveticus R0052 and Bifidobacterium longum R0175 (3 x 109 colony-forming units/stick). More detailed information about the product can be found on the manufacturer's website, www.institut-rosell-lallemand.com. Participants consume 1 probiotic stick a day for a period of 8 weeks. The stick is in the form of orodispersible powder and can be taken also without water. Following the RCT, participants enter an open-label trial for a further 8 week period with the same dose of Probio'stick.
Query!
Intervention code [1]
284918
0
Treatment: Other
Query!
Comparator / control treatment
The placebo group receives a placebo formula of identical taste and appearance: it consists of xylitol, maltodextrin (maize-derived), plum flavour and malic acid. Participant consume 1 placebo stick a day for a total of eight weeks. They then enter an open label trial for a further 8 week period with the same dose of Probio'Stick (ingredients described above).
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
287177
0
CGI - clinical global impression for mood, stress, anxiety and energy - from 1 to 7 how much better or worse from very much improved to very much worse. Assessed by participant.
Query!
Assessment method [1]
287177
0
Query!
Timepoint [1]
287177
0
RCT: Baseline and fortnightly for all the 8 week period.
Open-label extension: fortnightly for the 8 week period.
Query!
Primary outcome [2]
287178
0
The Depression Anxiety and Stress Scale (DASS) is a self-report questionnaire aimed at assessing an individual's current severity of symptoms relating to depression, anxiety and stress.
Query!
Assessment method [2]
287178
0
Query!
Timepoint [2]
287178
0
RCT: Baseline and fortnightly for the 8 week period.
Open-label extension: fortnightly for the 8 week period.
Query!
Primary outcome [3]
287179
0
Assessment of biomarkers:
- salivary cortisol
- high-sensitive C-reactive protein (blood)
- homocysteine (blood)
Query!
Assessment method [3]
287179
0
Query!
Timepoint [3]
287179
0
Baseline and 8 weeks (end of RCT phase).
Query!
Secondary outcome [1]
297559
0
The Kessler Psychological Distress Scale (K-10) measures non specific psychological distress in the depression-anxiety spectrum.
Query!
Assessment method [1]
297559
0
Query!
Timepoint [1]
297559
0
RCT: Baseline and fortnightly for all the 8 week period.
Open-label extension: fortnightly for the 8 week period.
Query!
Secondary outcome [2]
297560
0
The Profile of Mood States (POMS) is a measure of psychological distress and includes seven different scale: depression, anxiety, fatigue, vigour, irritability, tension and confusion.
Query!
Assessment method [2]
297560
0
Query!
Timepoint [2]
297560
0
RCT: 8 weeks ( baseline and end of RCT phase).
Open-label extension: end of open-label phase.
Query!
Secondary outcome [3]
297561
0
The Brief COPE is a brief form of the COPE Inventory.
It consists of 14 scales of two items each and represents a useful instrument to identify coping strategies.
Query!
Assessment method [3]
297561
0
Query!
Timepoint [3]
297561
0
RCT: Baseline and fortnightly for all the 8 week period.
Open-label extension: fortnightly for all the 8 week period.
Query!
Secondary outcome [4]
297562
0
A visual analogue scale (EQ-VAS) from the EuroQol questionnaire will ask participants to rate their current health state.
Query!
Assessment method [4]
297562
0
Query!
Timepoint [4]
297562
0
RCT: Baseline and fortnightly for all the 8 week period.
Open-label extension: fortnightly for all the 8 week period.
Query!
Secondary outcome [5]
297563
0
The Pennebaker Inventory of Limbic Languidness (PILL) assesses self-reported physical symptoms.
Query!
Assessment method [5]
297563
0
Query!
Timepoint [5]
297563
0
RCT: Baseline and fortnightly for all the 8 week period.
Open-label extension: fortnightly for all the 8 week period.
Query!
Secondary outcome [6]
297564
0
Bristol Stool Form Scale (BSFS) is a self-administered instrument useful to classify the form of human faeces into 7 types according to the seven images provided in the chart. It is widely used in clinical research and practice as it demonstrated to be a good measure of intestinal transit and thus a good indicator of the level of constipation/diarrhea of the subject.
Query!
Assessment method [6]
297564
0
Query!
Timepoint [6]
297564
0
RCT: participants will rate their faeces over the first and the last week of the trial.
Open-label extension: participants will rate their faeces over the last week of the trial.
Query!
Eligibility
Key inclusion criteria
1. Participants are older than 16 years of age.
2. Each participant must have a level of understanding sufficient to complete the questionnaires and examinations required by the protocol and be considered reliable and compliant with the protocol.
3. Participants meet at least one score above the cut-offs of the Depression Anxiety and Stress scale(DASS; Lovibond & Lovibond, 1995).
4. Participants must have been in Christchurch at the time of the one of the major earthquake (September 4th 2010; February 22nd 2011; June 13th 2011; Dec 23rd 2011).
5. Participants are free of psychotropic medication for the trial.
6. Participants who have not recently, within the last 4 days, suffered illness or have signs of inflammation.
Query!
Minimum age
16
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Neurological disorder involving brain or other central function (e.g., epilepsy, MS, narcolepsy).
2. Renal, hepatic, cardiovascular and respiratory diseases.
3. Any serious medical condition for which major medical interventions are anticipated during the duration of the trial.
4. Any patient known to have food allergy or to be allergic to the ingredients of the intervention.
5. Pregnancy or breastfeeding
6. Evidence of substance dependence within the previous month.
7. Any other medication with primarily central nervous system activity, including mood stabilizers. Participants must have been off of these medications for a minimum of four weeks prior to the trial.
8. Patients will be excluded temporarily if they have taken an oral antibiotic in the previous 6 weeks. If an antibiotic is begun during the course of the trial, that patient will be withdrawn from the study.
9. Any type of nutritional or herbal supplement (ginger, guarana, ginseng, dehydroepiandrosterone, melatonin, antioxidants, selenium, replacement hormones) known to have a centrally-acting effect, will result in a patient’s exclusion.
10. Any subject judged clinically to be at serious risk for suicide or violence in the opinion of the researchers.
11. Participants will be asked to minimize their intake of colas, tea, coffee, alcohol, cigarettes and illicit drugs. These substances will be monitored as part of the trial.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
If an individual meets the inclusion criteria and does not meet the exclusion criteria, he/she will be allocated to the next available number. All sticks( active ingredient or placebo) have been pre-packaged by the pharmacy which holds the randomisation code. A sealed envelope is contained within each stick package only to be opened in an emergency (i.e. a patient deteriorates significantly).
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
We will set up 4 tables of random numbers (mix of 1s and 2s representing the probiotic or placebo). We will give these four sets to the Pharmacy (David Pugh-Williams at the Christchurch Public Hospital), who will selected one of them --- and of course we will not know which one. The study pharmacist prepares in advance a participant kit which contains all the medication bottles required over the eight weeks for each participant. These kits are sequentially numbered and allocated to placebo or probiotic based on the randomisation list. Once a participant’s eligibility has been confirmed they will be allocated the next sequentially numbered kit and dispensed adequate powder for the duration of the trial. In this manner neither the participant nor the PI nor the clinician nor the observer, assessing the participant’s outcomes are aware of the participant’s allocated study group.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
The randomized phase is followed with an open-label trial
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Withdrawn
Query!
Reason for early stopping/withdrawal
Query!
Date of first participant enrolment
Anticipated
1/08/2012
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
63
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
4330
0
New Zealand
Query!
State/province [1]
4330
0
Query!
Funding & Sponsors
Funding source category [1]
285309
0
University
Query!
Name [1]
285309
0
University of Canterbury
Query!
Address [1]
285309
0
Department of Psychology
Private Bag 4800
Christchurch
Canterbury
8140
Query!
Country [1]
285309
0
New Zealand
Query!
Primary sponsor type
University
Query!
Name
University of Canterbury
Query!
Address
Department of Psychology
Private Bag 4800
Christchurch
Canterbury
8140
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
284319
0
None
Query!
Name [1]
284319
0
Query!
Address [1]
284319
0
Query!
Country [1]
284319
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
287325
0
Upper South A Regional Ethics Committee
Query!
Ethics committee address [1]
287325
0
c/- Ministry of Health Montgomery Watson Building 6 Hazeldean Road Christchurch 8024
Query!
Ethics committee country [1]
287325
0
New Zealand
Query!
Date submitted for ethics approval [1]
287325
0
Query!
Approval date [1]
287325
0
12/06/2012
Query!
Ethics approval number [1]
287325
0
URA/12/05/013
Query!
Summary
Brief summary
The purpose of this study is to evaluate the effect of a probiotic supplement on the treatment of psychological symptoms, such as stress, anxiety and depression, associated with the earthquake experience and its negative consequences on quality of life. Seismic events can cause serious problems of adaptation and lead to significant changes which can affect the daily management of your life. If these situations persist, they can promote an increase in the level of important biological indicators (biomarkers) that regulate your stress response, with consequent harmful effects on your health. Recent studies have demonstrated that the gut is able to communicate with the brain and that the consumption of beneficial gut bacteria can improve psychological symptoms and reduce the level of some relevant biomarkers. The aim of this research is to assess the therapeutic role of a specific probiotic formula in treating these stress-related symptoms.
Query!
Trial website
www.mentalhealthandnutrition.co.nz
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
34216
0
A/Prof Julia Rucklidge
Query!
Address
34216
0
University of Canterbury
Private Bag 4800
Christchurch New Zealand
Query!
Country
34216
0
New Zealand
Query!
Phone
34216
0
+6433642987
Query!
Fax
34216
0
+6433642181
Query!
Email
34216
0
julia.rucklidge@canterbury.ac.nz
Query!
Contact person for public queries
Name
17463
0
Assoc. Prof. Julia Rucklidge
Query!
Address
17463
0
Dept of Psychology
University of Canterbury
Private bag 4800
Christchurch
8140
Query!
Country
17463
0
New Zealand
Query!
Phone
17463
0
6433642987 ext 7959
Query!
Fax
17463
0
6433642181
Query!
Email
17463
0
julia.rucklidge@canterbury.ac.nz
Query!
Contact person for scientific queries
Name
8391
0
Ass. Prof. Julia Rucklidge
Query!
Address
8391
0
Dept of Psychology
University of Canterbury
Private bag 4800
Christchurch
8140
Query!
Country
8391
0
New Zealand
Query!
Phone
8391
0
+6433642987 ext 7959
Query!
Fax
8391
0
6433642181
Query!
Email
8391
0
julia.rucklidge@canterbury.ac.nz
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF